These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21284700)

  • 1. The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study).
    Zaky S; Fouad EA; Kotb HI
    Br J Clin Pharmacol; 2011 Mar; 71(3):411-5. PubMed ID: 21284700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.
    Bocci V; Zanardi I; Travagli V
    Br J Clin Pharmacol; 2011 Aug; 72(2):350-1; author reply 352. PubMed ID: 21446933
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis.
    Schepke M; Raab P; Hoppe A; Brensing K; Paar D; Potyka U; Sauerbruch T
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1451-8. PubMed ID: 10571601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of effects of propranolol on portal hemodynamics in cirrhosis by duplex ultrasonography.
    Saigal S; Chawla Y; Dilawari JB
    Indian J Gastroenterol; 1998 Apr; 17(2):51-2. PubMed ID: 9563219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of propranolol on portal vein hemodynamics in patients with liver cirrhosis: assessment by duplex sonography.
    Zoller WG; Wagner DR; Zentner J
    Z Gastroenterol; 1993; 31(7-8):425-8. PubMed ID: 8379228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol for portal hypertension. Evaluation of therapeutic response by direct measurement of portal vein pressure.
    Rector WG
    Arch Intern Med; 1985 Apr; 145(4):648-50. PubMed ID: 3985727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
    Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
    Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effects of molsidomine and propranolol-molsidomine combination on portal hemodynamics by pulsed Doppler ultrasound].
    Monnin JL; Vinel JP; Le Quellec A; Pascal JP; Taourel P; Bruel JM; Blanc F; Michel H; Ciurana AJ
    Gastroenterol Clin Biol; 1992; 16(10):745-50. PubMed ID: 1478400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
    Castaño G; Viudez P; Riccitelli M; Sookoian S
    Ann Hepatol; 2003; 2(1):36-40. PubMed ID: 15094704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
    Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
    Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II].
    Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S
    Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis].
    Sychev DA; Parusov AI; Loranskaya ID; Denisenko NP; Akmalova KA; Sozaeva ZA; Turkina OL; Zastrozhin MS
    Ter Arkh; 2022 Feb; 94(2):200-208. PubMed ID: 36286743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
    Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
    Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
    Andreu V; Perello A; Moitinho E; Escorsell A; García-Pagán JC; Bosch J; Rodés J
    J Hepatol; 2002 Mar; 36(3):356-61. PubMed ID: 11867179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of propranolol on portal venous pressure.
    Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
    Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.